Crestchem

₹114.5 -0.7 | 0.6%

WEBSITE BSE:526269 NSE : CRESTCHEM LT 18 May, 12:50

Market Cap ₹34 Cr.

Stock P/E 18.6

P/B 8.1

Current Price ₹114.5

Book Value ₹ 14.1

Face Value 10

52W High ₹144.9

Dividend Yield 0%

52W Low ₹ 58.4

Edit Ratio

Crestchem Research see more...

Overview Inc. Year: 1991Industry: Chemicals

Crestchem Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Crestchem Quarterly Results

#(Fig in Cr.)	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Jun 2023	Sep 2023	Dec 2023
Net Sales	1	0	3	4	5	4	5	4	4	7
Other Income	0	0	0	0	0	0	0	0	0	0
Total Income	2	0	3	4	5	4	5	4	5	7
Total Expenditure	1	0	2	3	5	4	5	3	4	6
Operating Profit	0	-0	0	0	0	0	0	0	0	1
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	-0	0	0	0	0	0	0	0	1
Provision for Tax	0	-0	0	0	0	0	0	0	0	0
Profit After Tax	0	-0	0	0	0	0	0	0	0	1
Adjustments	-0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	0	-0	0	0	0	0	0	0	0	1
Adjusted Earnings Per Share	0.4	-0.2	0.7	0.9	0.5	0.4	1.2	0.8	1.1	3

Crestchem Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	0	0	0	0	0	0	0	6	8	8	17	20
Other Income	0	0	1	0	0	0	0	0	0	0	0	0
Total Income	0	0	1	0	0	0	0	6	8	8	17	21
Total Expenditure	0	0	0	0	0	0	0	6	7	7	16	18
Operating Profit	0	0	1	0	-0	-0	-0	1	1	1	1	1
Interest	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	-0	-0	1	0	-0	-0	-0	1	1	1	1	1
Provision for Tax	0	0	0	0	0	-0	0	0	0	0	0	0
Profit After Tax	-0	-0	1	0	-0	-0	-0	0	1	1	1	1
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-0	-0	1	0	-0	-0	-0	0	1	1	1	1
Adjusted Earnings Per Share	-0.3	-0.1	2	0.3	-0.5	-0.6	-0.6	1.5	1.9	1.9	2.3	6.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	113%	42%	0%	0%
Operating Profit CAGR	0%	0%	0%	0%
PAT CAGR	0%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	42%	49%	50%	25%
ROE Average	29%	36%	28%	16%
ROCE Average	38%	40%	33%	19%

Crestchem Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	0	0	1	1	1	1	0	1	1	2	3
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	-0	-0	0	0	0	0
Total Current Liabilities	1	1	1	0	1	0	0	1	1	1	2
Total Liabilities	1	1	1	1	1	1	1	2	3	3	5
Fixed Assets	1	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	2	3
Total Current Assets	0	1	1	1	1	1	1	2	3	1	1
Total Assets	1	1	1	1	1	1	1	2	3	3	5

Crestchem Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0	0	0	0	1	0	0	0	0	0
Cash Flow from Operating Activities	-0	-0	0	-0	-0	-1	-0	0	0	1	2
Cash Flow from Investing Activities	0	0	0	0	1	0	0	-0	-0	-1	-1
Cash Flow from Financing Activities	-0	0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Net Cash Inflow / Outflow	0	-0	0	0	1	-1	-0	-0	-0	-0	1
Closing Cash & Cash Equivalent	0	0	0	0	1	0	0	0	0	0	1

Crestchem Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-0.27	-0.09	2.04	0.29	-0.54	-0.65	-0.57	1.48	1.91	1.89	2.31
CEPS(Rs)	0.02	0.19	2.2	0.29	-0.54	-0.64	-0.53	1.55	1.99	1.98	2.39
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	1.44	1.36	3.05	3.33	2.79	2.15	1.58	3.06	4.98	6.87	9.18
Core EBITDA Margin(%)	-193.52	13.02	-150.78	-45.71	-142.62	-476.04	-161.32	9.18	8.62	9.41	4.95
EBIT Margin(%)	-45.69	1.26	738.7	101.75	-84.14	-418.68	-152.63	9.26	9.02	10.03	5.7
Pre Tax Margin(%)	-90.54	-6.19	720.15	89.44	-115.24	-432.65	-158.6	9.18	8.81	9.83	5.61
PAT Margin (%)	-90.54	-6.21	644.75	64.82	-115.24	-373.09	-162.5	7.15	7.51	7.14	4.15
Cash Profit Margin (%)	5.98	13.79	696.23	64.94	-115.13	-367.38	-151.72	7.48	7.83	7.46	4.28
ROA(%)	-7.87	-2.24	43.75	5.9	-11.19	-17.01	-20.59	28.16	21.71	18.03	17.17
ROE(%)	-16.87	-6.17	92.53	8.94	-17.61	-26.13	-30.33	63.73	47.63	31.94	28.82
ROCE(%)	-5.35	0.68	67.18	10.22	-8.5	-19.57	-20.62	67.91	45.15	35.85	37.52
Receivable days	212.61	191.22	789.04	162.96	381.79	965.4	311.81	37.97	62.57	52.99	9.96
Inventory Days	79.7	7.29	32.36	21.12	14.8	0	23.33	0.38	0.22	0.13	0
Payable days	559.44	251.07	852.33	104.98	28.22	44.71	211.17	46.16	50	32	30.76
PER(x)	0	0	5.2	34.01	0	0	0	7.44	13.69	21.69	52.97
Price/Book(x)	6.92	9.27	3.48	2.91	4.46	5.82	9.32	3.59	5.27	5.97	13.34
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	37.06	9.52	23.13	19.16	22.94	68.86	42.24	0.43	0.98	1.58	2.14
EV/Core EBITDA(x)	72.92	44.78	2.93	18.8	-27.3	-16.67	-29.78	4.5	10.53	15.26	36.77
Net Sales Growth(%)	-27.96	373.37	-77.3	39.19	6.37	-63.04	101.16	5843.38	23.16	4	110.49
EBIT Growth(%)	-194.69	113.03	0	-80.83	-187.96	-83.92	26.66	460.55	20	15.61	19.57
PAT Growth(%)	-293.39	67.54	2458.02	-86.01	-289.12	-19.67	12.39	361.62	29.37	-1.21	22.26
EPS Growth(%)	-293.41	67.54	2458.06	-86.01	-289.11	-19.67	12.38	361.6	29.37	-1.21	22.26
Debt/Equity(x)	0.7	0.98	0.4	0.35	0.71	0.22	0.6	0.02	0.42	0.13	0
Current Ratio(x)	0.46	0.92	2.47	2.24	2.1	3.19	1.51	1.52	1.85	0.96	0.6
Quick Ratio(x)	0.69	1.21	2.44	2.24	2.09	3.19	1.5	1.51	1.85	0.96	0.6
Interest Cover(x)	-1.02	0.17	39.82	8.27	-2.71	-29.97	-25.59	116.69	42.92	50.55	64.66
Total Debt/Mcap(x)	0.1	0.11	0.12	0.12	0.16	0.04	0.06	0	0.08	0.02	0

Crestchem Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	31.8	31.89	31.94	31.87	31.95	31.44	31.65	31.92	32.09	32.11
FII	0	0	0	0	0	0	0	0	0	0
DII	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13
Public	68.07	67.98	67.93	68	67.92	68.43	68.22	67.95	67.78	67.76
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.1	0.1	0.1	0.1	0.1	0.09	0.09	0.1	0.1	0.1
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.2	0.2	0.2	0.2	0.2	0.21	0.2	0.2	0.2	0.2
Others	0	0	0	0	0	0	0	0	0	0
Total	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 36%
Debtor days have improved from 32 to 30.76days.
Company is almost debt free.

Cons

Promoter holding is low: 32.11%.
Stock is trading at 8.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.